Literature DB >> 31619524

Predominance of Th1 Immune Response in Pleural Effusion of Patients with Tuberculosis among Other Exudative Etiologies.

Vinícius da Cunha Lisboa1, Marcelo Ribeiro-Alves2, Raquel da Silva Corrêa1, Isabelle Ramos Lopes1, Thiago Thomaz Mafort3, Ana Paula Santos3, Thaís Porto Amadeu1, Rogério Rufino3, Luciana Silva Rodrigues4.   

Abstract

Pleural tuberculosis (PlTB), a common form of extrapulmonary TB, remains a challenge in the diagnosis among many causes of pleural effusion. We recently reported that the combinatorial analysis of interferon gamma (IFN-γ), IFN-γ-inducible protein 10 (IP-10), and adenosine deaminase (ADA) from the pleural microenvironment was useful to distinguish pleural effusion caused by TB (microbiologically confirmed or not) among other etiologies. In this cross-sectional cohort study, a set of inflammatory mediators was quantified in blood and pleural fluid (PF) from exudative pleural effusion cases, including PlTB (n = 27) and non-PlTB (nTB) (n = 25) patients. The levels of interleukin-2 (IL-2), IL-4, IL-6, IL-10, IL-17A, IFN-γ, tumor necrosis factor (TNF), IP-10, transforming growth factor β1 (TGF-β), and ADA were determined using cytometric bead assay, enzyme-linked immunosorbent assay (ELISA), or biochemical tests. IFN-γ, IP-10, TNF, TGF-β, and ADA quantified in PF showed significantly higher concentrations in PlTB patients than in nTB patients. When blood and PF were compared, significantly higher concentrations of IL-6 and IL-10 in PF were identified in both groups. TGF-β, solely, showed significantly increased levels in PF and blood from PlTB patients when both clinical specimens were compared to those from nTB patients. Principal-component analysis (PCA) revealed a T helper type 1 (Th1) pattern attributed mainly to higher levels of IP-10, IFN-γ, TGF-β, and TNF in the pleural cavity, which was distinct between PlTB and nTB. In conclusion, our findings showed a predominantly cellular immune response in PF from TB cases, rather than other causes of exudative effusion commonly considered in the differential diagnosis of PlTB.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  IP-10; Th1 response; adenosine deaminase; cytokines in pleural effusion; pleural effusion; pleural tuberculosis; transforming growth factor-beta

Year:  2019        PMID: 31619524      PMCID: PMC6935897          DOI: 10.1128/JCM.00927-19

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  40 in total

Review 1.  IP-10 release assays in the diagnosis of tuberculosis infection: current status and future directions.

Authors:  Morten Ruhwald; Martine G Aabye; Pernille Ravn
Journal:  Expert Rev Mol Diagn       Date:  2012-03       Impact factor: 5.225

2.  Correction for Aggarwal et al., Interferon Gamma Release Assays for Diagnosis of Pleural Tuberculosis: a Systematic Review and Meta-Analysis.

Authors:  Ashutosh N Aggarwal; Ritesh Agarwal; Dheeraj Gupta; Sahajal Dhooria; Digambar Behera
Journal:  J Clin Microbiol       Date:  2016-02       Impact factor: 5.948

3.  Predominance of Th17 over regulatory T-cells in pleural effusions of patients with lung cancer implicates a proinflammatory profile.

Authors:  Heriberto Prado-Garcia; Susana Romero-Garcia; Uriel Rumbo-Nava; Jose Sullivan Lopez-Gonzalez
Journal:  Anticancer Res       Date:  2015-03       Impact factor: 2.480

4.  Adenosine deaminase (ADA) isoenzyme analysis in pleural effusions: diagnostic role, and relevance to the origin of increased ADA in tuberculous pleurisy.

Authors:  L Valdés; E San José; D Alvarez; J M Valle
Journal:  Eur Respir J       Date:  1996-04       Impact factor: 16.671

5.  Diagnostic value of adenosine deaminase in nontuberculous lymphocytic pleural effusions.

Authors:  D Jiménez Castro; G Díaz Nuevo; E Pérez-Rodríguez; R W Light
Journal:  Eur Respir J       Date:  2003-02       Impact factor: 16.671

Review 6.  Advances in the diagnosis of tuberculous pleuritis.

Authors:  José M Porcel
Journal:  Ann Transl Med       Date:  2016-08

7.  CD39+ regulatory T cells suppress generation and differentiation of Th17 cells in human malignant pleural effusion via a LAP-dependent mechanism.

Authors:  Zhi-Jian Ye; Qiong Zhou; Jian-Chu Zhang; Xiao Li; Cong Wu; Shou-Ming Qin; Jian-Bao Xin; Huan-Zhong Shi
Journal:  Respir Res       Date:  2011-06-10

8.  Diagnostic accuracy of tumor necrosis factor-alpha, interferon-gamma, interleukin-10 and adenosine deaminase 2 in differential diagnosis between tuberculous pleural effusion and malignant pleural effusion.

Authors:  Mingying Li; Helin Wang; Xia Wang; Jian Huang; Junxiang Wang; Xiue Xi
Journal:  J Cardiothorac Surg       Date:  2014-07-01       Impact factor: 1.637

Review 9.  Th1 and Th17 Cells in Tuberculosis: Protection, Pathology, and Biomarkers.

Authors:  I V Lyadova; A V Panteleev
Journal:  Mediators Inflamm       Date:  2015-11-10       Impact factor: 4.711

10.  Application of Venn's diagram in the diagnosis of pleural tuberculosis using IFN-γ, IP-10 and adenosine deaminase.

Authors:  Ana Paula Santos; Raquel da Silva Corrêa; Marcelo Ribeiro-Alves; Ana Carolina Oliveira Soares da Silva; Thiago Thomaz Mafort; Janaína Leung; Geraldo Moura Batista Pereira; Luciana Silva Rodrigues; Rogério Rufino
Journal:  PLoS One       Date:  2018-08-27       Impact factor: 3.240

View more
  2 in total

1.  T Helper Cell Subsets in the Pleural Fluid of Tuberculous Patients Differentiate Patients With Non-Tuberculous Pleural Effusions.

Authors:  Neda Dalil Roofchayee; Ian M Adcock; Majid Marjani; Neda K Dezfuli; Mohammad Varahram; Johan Garssen; Esmaeil Mortaz
Journal:  Front Immunol       Date:  2021-12-02       Impact factor: 7.561

2.  Single-cell immune profiling reveals functional diversity of T cells in tuberculous pleural effusion.

Authors:  Yi Cai; Yejun Wang; Chenyan Shi; Youchao Dai; Fuxiang Li; Yuzhong Xu; Peize Zhang; Fanhui Kong; Guofang Deng; Zhihua Wen; Qi Zhou; Boxi Chris Kang; Amit Singhal; Qianting Yang; Carl G Feng; Xinchun Chen
Journal:  J Exp Med       Date:  2022-01-21       Impact factor: 17.579

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.